Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current therapy of multiple sclerosis.

K P Johnson1, J R Baringer

  • 1Department of Neurology, University of Maryland School of Medicine, Baltimore, USA.

Hospital Practice (1995)
|May 1, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dendritic and parallel processing of visual threats in the retina control defensive responses.

Science advances·2020
Same author

Development and Characterization of 12 Novel Polymorphic Microsatellite Loci for the Mammal Chewing Louse Geomydoecus aurei (Insecta: Phthiraptera) and a Comparison of Next-Generation Sequencing Approaches for Use in Parasitology.

The Journal of parasitology·2017
Same author

Patterns of cryptic host specificity in duck lice based on molecular data.

Medical and veterinary entomology·2016
Same author

Parallel evolution in the major haemoglobin genes of eight species of Andean waterfowl.

Molecular ecology·2009
Same author

Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2007
Same author

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2006
Same journal

A rocking biologic prosthetic valve: <i>Cutibacterium acnes</i> prosthetic valve endocarditis.

Hospital practice (1995)·2026
Same journal

Diagnostic accuracy of the Wells score versus duplex ultrasound for deep vein thrombosis in a Ghanaian cohort.

Hospital practice (1995)·2026
Same journal

Examining the frequency and factors related to the occurrence of deep vein thrombosis (DVT) in patients undergoing posterior fixation of the lumbosacral spine (PSF).

Hospital practice (1995)·2025
Same journal

The impact of hospitalist experience on patient outcomes: a retrospective cohort analysis at an academic medical center.

Hospital practice (1995)·2025
Same journal

The efficacy of melatonin as a preoperative anxiolytic in real-world setting: a randomized controlled trial.

Hospital practice (1995)·2025
Same journal

Antibiotic prescription patterns among hospitalized patients with influenza: a cross-sectional study in a tertiary referral hospital in Iran.

Hospital practice (1995)·2025
See all related articles

Medications for immune modulation and symptom relief are expanding. Optimal treatment integrates drug therapy with patient education and physical therapy for a comprehensive approach.

Area of Science:

  • Immunology
  • Pharmacology
  • Rehabilitation Medicine

Background:

  • The therapeutic landscape for immune modulation and symptomatic relief is continually evolving with new drug development.
  • There is an increasing need for integrated treatment strategies beyond pharmacotherapy.

Observation:

  • Drug therapy is a cornerstone in managing conditions requiring immune modulation and symptom management.
  • Current treatment paradigms are expanding to include a wider array of pharmacological agents.

Findings:

  • The growing list of medications offers more options for immune modulation and symptom relief.
  • Pharmacological interventions are increasingly recognized as one component of a broader therapeutic strategy.

Implications:

Related Experiment Videos

  • Future treatment protocols should emphasize a multidisciplinary approach, combining drug therapy with non-pharmacological interventions.
  • Integrating patient education and physical therapy alongside medication can enhance overall patient outcomes and management.
  • This integrated approach is crucial for optimizing patient care in conditions requiring immune modulation and symptomatic relief.